325 related articles for article (PubMed ID: 33301050)
21. Kappa opioid receptor activation potentiates the cocaine-induced increase in evoked dopamine release recorded in vivo in the mouse nucleus accumbens.
Ehrich JM; Phillips PE; Chavkin C
Neuropsychopharmacology; 2014 Dec; 39(13):3036-48. PubMed ID: 24971603
[TBL] [Abstract][Full Text] [Related]
22. Kappa-Opioid Antagonists for Psychiatric Disorders: From Bench to Clinical Trials.
Carlezon WA; Krystal AD
Depress Anxiety; 2016 Oct; 33(10):895-906. PubMed ID: 27699938
[TBL] [Abstract][Full Text] [Related]
23. Optogenetic stimulation of dynorphinergic neurons within the dorsal raphe activate kappa opioid receptors in the ventral tegmental area and ablation of dorsal raphe prodynorphin or kappa receptors in dopamine neurons blocks stress potentiation of cocaine reward.
Abraham AD; Casello SM; Land BB; Chavkin C
Addict Neurosci; 2022 Mar; 1():. PubMed ID: 36176476
[TBL] [Abstract][Full Text] [Related]
24. The one-two punch of alcoholism: role of central amygdala dynorphins/kappa-opioid receptors.
Kissler JL; Sirohi S; Reis DJ; Jansen HT; Quock RM; Smith DG; Walker BM
Biol Psychiatry; 2014 May; 75(10):774-82. PubMed ID: 23611261
[TBL] [Abstract][Full Text] [Related]
25. The role of the dynorphin-kappa opioid system in the reinforcing effects of drugs of abuse.
Wee S; Koob GF
Psychopharmacology (Berl); 2010 Jun; 210(2):121-35. PubMed ID: 20352414
[TBL] [Abstract][Full Text] [Related]
26. Cocaine self-administration augments kappa opioid receptor system-mediated inhibition of dopamine activity in the mesolimbic dopamine system.
Estave PM; Sun H; Peck EG; Holleran KM; Chen R; Jones SR
IBRO Neurosci Rep; 2023 Jun; 14():129-137. PubMed ID: 36748012
[TBL] [Abstract][Full Text] [Related]
27. Theoretical Frameworks and Mechanistic Aspects of Alcohol Addiction: Alcohol Addiction as a Reward Deficit/Stress Surfeit Disorder.
Koob GF; Vendruscolo L
Curr Top Behav Neurosci; 2023 Jul; ():. PubMed ID: 37421551
[TBL] [Abstract][Full Text] [Related]
28. Traumatic Stress-Induced Vulnerability to Addiction: Critical Role of the Dynorphin/Kappa Opioid Receptor System.
Leconte C; Mongeau R; Noble F
Front Pharmacol; 2022; 13():856672. PubMed ID: 35571111
[TBL] [Abstract][Full Text] [Related]
29. Stress-Induced Reinstatement of Nicotine Preference Requires Dynorphin/Kappa Opioid Activity in the Basolateral Amygdala.
Nygard SK; Hourguettes NJ; Sobczak GG; Carlezon WA; Bruchas MR
J Neurosci; 2016 Sep; 36(38):9937-48. PubMed ID: 27656031
[TBL] [Abstract][Full Text] [Related]
30. Activation of the kappa opioid receptor in the dorsal raphe nucleus mediates the aversive effects of stress and reinstates drug seeking.
Land BB; Bruchas MR; Schattauer S; Giardino WJ; Aita M; Messinger D; Hnasko TS; Palmiter RD; Chavkin C
Proc Natl Acad Sci U S A; 2009 Nov; 106(45):19168-73. PubMed ID: 19864633
[TBL] [Abstract][Full Text] [Related]
31. Cell-type and projection-specific dopaminergic encoding of aversive stimuli in addiction.
Thibeault KC; Kutlu MG; Sanders C; Calipari ES
Brain Res; 2019 Jun; 1713():1-15. PubMed ID: 30580012
[TBL] [Abstract][Full Text] [Related]
32. Behavioral stress may increase the rewarding valence of cocaine-associated cues through a dynorphin/kappa-opioid receptor-mediated mechanism without affecting associative learning or memory retrieval mechanisms.
Schindler AG; Li S; Chavkin C
Neuropsychopharmacology; 2010 Aug; 35(9):1932-42. PubMed ID: 20445500
[TBL] [Abstract][Full Text] [Related]
33. Upregulation of dynorphin/kappa opioid receptor system in the dorsal hippocampus contributes to morphine withdrawal-induced place aversion.
Chen Y; Wang CY; Zan GY; Yao SY; Deng YZ; Shu XL; Wu WW; Ma Y; Wang YJ; Yu CX; Liu JG
Acta Pharmacol Sin; 2023 Mar; 44(3):538-545. PubMed ID: 36127507
[TBL] [Abstract][Full Text] [Related]
34. Dynorphin/Kappa-Opioid Receptor System Modulation of Cortical Circuitry.
Tejeda HA; Wang H; Flores RJ; Yarur HE
Handb Exp Pharmacol; 2022; 271():223-253. PubMed ID: 33580392
[TBL] [Abstract][Full Text] [Related]
35. Supersensitive Kappa Opioid Receptors Promotes Ethanol Withdrawal-Related Behaviors and Reduce Dopamine Signaling in the Nucleus Accumbens.
Rose JH; Karkhanis AN; Chen R; Gioia D; Lopez MF; Becker HC; McCool BA; Jones SR
Int J Neuropsychopharmacol; 2016 May; 19(5):. PubMed ID: 26625893
[TBL] [Abstract][Full Text] [Related]
36. Dopaminergic cellular and circuit contributions to kappa opioid receptor mediated aversion.
Margolis EB; Karkhanis AN
Neurochem Int; 2019 Oct; 129():104504. PubMed ID: 31301327
[TBL] [Abstract][Full Text] [Related]
37. Does the kappa opioid receptor system contribute to pain aversion?
Cahill CM; Taylor AM; Cook C; Ong E; Morón JA; Evans CJ
Front Pharmacol; 2014; 5():253. PubMed ID: 25452729
[TBL] [Abstract][Full Text] [Related]
38. Females are less sensitive than males to the motivational- and dopamine-suppressing effects of kappa opioid receptor activation.
Conway SM; Puttick D; Russell S; Potter D; Roitman MF; Chartoff EH
Neuropharmacology; 2019 Mar; 146():231-241. PubMed ID: 30528327
[TBL] [Abstract][Full Text] [Related]
39. Dynorphin/kappa-opioid receptor control of dopamine dynamics: Implications for negative affective states and psychiatric disorders.
Tejeda HA; Bonci A
Brain Res; 2019 Jun; 1713():91-101. PubMed ID: 30244022
[TBL] [Abstract][Full Text] [Related]
40. Kappa Opioid Receptor Mediated Differential Regulation of Serotonin and Dopamine Transporters in Mood and Substance Use Disorder.
Ragu Varman D; Jayanthi LD; Ramamoorthy S
Handb Exp Pharmacol; 2022; 271():97-112. PubMed ID: 34136961
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
